Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.

Stock
Quote

Webcasts

11/15/2022
at 12:00 AM PST
06/09/2022
at 11:30 AM EDT
03/09/2022
at 11:10 AM PST

Financial Information

Document Date Description Form View

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Report of unscheduled material events or corporate event

8-K View HTML EX-101.LAB - XBRL LABEL FILE

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Report of unscheduled material events or corporate event

8-K View HTML EX-101.DEF - XBRL DEFINITION FILE

Amendment to a previously filed 8-A12B

8-A12B/A View HTML

Report of unscheduled material events or corporate event

8-K View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Contact
IR

Send us an investor-related question using the form below.